Unsupervised machine learning identifies early stage breast cancer subclasses from aberrant glycogene expression and informs personalised drug treatment

Abstract Unsupervised hierarchical clustering of early-stage breast cancer glycogene expression data using the Growing Hierarchical Self Organising Representation Map (GHSORM) algorithm identified seven subclasses. These glycogene expression clusters (GECs) overlap with known breast cancer biomarkers such as hormone receptor status and immune signatures. Feature discovery via Recursive Feature Elimination with Strikeout (RFES) identified a panel of 60 glycogenes that can predict GECs on an independent testing set with 90.48% accuracy. GEC-based subtyping of patients from the I-SPY2 clinical trial revealed an 86% pathologic complete response (pCR), demonstrating how glycogene expression in combination with custom machine learning algorithms could be an approach to molecular cancer diagnosis capable of informing personalised drug treatment.

Authors

Institutions

Publication Details

Journal
Discover Chemistry.
Published
2026-11-14
DOI
https://doi.org/10.1007/s44371-026-01070-0
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Unsupervised machine learning identifies early stage breast cancer subclasses from aberrant glycogene expression and informs personalised drug treatment

Kevin J. Naidoo, Mia Venter
2 links
Discover Chemistry.
Breast Cancer Treatment Studies
article

Unsupervised machine learning identifies early stage breast cancer subclasses from aberrant glycogene expression and informs personalised drug treatment

Kevin J. Naidoo, Mia Venter
article en

Abstract

Abstract Unsupervised hierarchical clustering of early-stage breast cancer glycogene expression data using the Growing Hierarchical Self Organising Representation Map (GHSORM) algorithm identified seven subclasses. These glycogene expression clusters (GECs) overlap with known breast cancer biomarkers such as hormone receptor status and immune signatures. Feature discovery via Recursive Feature Elimination with Strikeout (RFES) identified a panel of 60 glycogenes that can predict GECs on an independent testing set with 90.48% accuracy. GEC-based subtyping of patients from the I-SPY2 clinical trial revealed an 86% pathologic complete response (pCR), demonstrating how glycogene expression in combination with custom machine learning algorithms could be an approach to molecular cancer diagnosis capable of informing personalised drug treatment.

Discover Chemistry.Vol. 3(1)
University of Cape Town (ZA)
Dane O. Kildsig Center for Pharmaceutical Processing Research, South African Medical Research Council, University of Cape Town, Center for High Performance Computing, Medical Research Council
Good health and well-being
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon